GlassScriptPhysician profile
Jason Jensen
NPI 1881128221
$10,716.95
in general payments reported to CMS, 2019-2025
14 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,308 · 2023: $6,426 · 2024: $750 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,381 · Travel and Lodging: $19.00 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,381.29 |
| Travel and Lodging | $19.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,545.62 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Novo Nordisk INC | $266.59 | 2023-2025 | Wegovy |
| Teleflex LLC | $206.49 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Stryker Corporation | $170.37 | 2022 | |
| Davol INC. | $147.62 | 2023 | Arista Ah Flexitip |
| Endogastric Solutions, INC | $136.78 | 2023-2024 | Esophyx |
| Medtronic, INC. | $96.93 | 2022 | |
| Standard Bariatrics, INC. | $36.28 | 2022 | |
| Currax Pharmaceuticals LLC | $26.03 | 2022 | |
| Becton, Dickinson and Company | $22.57 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.40 | 2022 | |
| Acera Surgical, INC. | $16.21 | 2023 | Restrata Wound Matrix |
| Ethicon US, LLC | $15.50 | 2024 | Linx Reflux Management System, Harmonic |
| Abbvie INC. | $13.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.